Evaluation of selective competitive binding of basic drugs to α1-acid glycoprotein variants

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 1, 2010, Pages 95-99

  Ishizaki, Junko ^a   Fukaishi, Akiko ^a   Fukuwa, Chie ^a   Yamazaki, Satoko ^a   Tabata, Mayu ^a   Ishida, Takuya ^a   Suga, Yukio ^a   Arai, Kunizo ^a   Yokogawa, Koichi ^a   Miyamoto, Ken Ichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

1 acid glycoprotein; Dissociation constant; Drug interaction; Inhibition constant; Protein binding; Variant

Indexed keywords

ACRIDINE ORANGE; AMLODIPINE BESYLATE; ANAPEINE; CARVEDILOL; CUPRIC ION; DICOUMAROL; DILTIAZEM; DIPYRIDAMOLE; DISOPYRAMIDE; LIDOCAINE; MEPIVACAINE; NIFEDIPINE; OROSOMUCOID; ROPIVACAINE; RYTHMODAN P; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CHROMATOGRAPHY; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG INTERACTION; DRUG PROTEIN BINDING; EQUILIBRIUM DIALYSIS; GENETIC VARIABILITY; PROTEIN VARIANT;

ACRIDINE ORANGE; BINDING, COMPETITIVE; CIRCULAR DICHROISM; DICUMAROL; DIPYRIDAMOLE; DISOPYRAMIDE; DRUG INTERACTIONS; GENETIC VARIATION; HUMANS; OROSOMUCOID; PHARMACEUTICAL PREPARATIONS; SPECTRUM ANALYSIS;

EID: 75149129102     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.95     Document Type: Article

References (18)

1. Holley F. O., Ponganis K. V., Stanski D. R., Clin. Pharmacol. Ther., 35, 617-626 (1984).
2. Booker P. D., Taylor C., Saba G., Br. J. Anaesth., 76, 365-368 (1996).
3. Yokogawa K., Shimomura S., Ishizaki J., Shimada T., Fukuwa C., Kawada M., Tsubokawa T., Yamamoto K., Miyamoto K., J. Pharm. Pharmacol., 59, 67-73 (2007).
4. Piafsky K. M., Borga O., Odar-Cederlof I., Johansson C., Sjoqvist F., N. Engl. J. Med., 229, 1435-1439 (1978).
5. Trautner K., Cooper E. H., Haworth S., Ward A. M., Scand. J. Urol. Nephrol., 14, 143-149 (1980).
6. Raynes J., Biomed. Pharmacother., 36, 77-86 (1982).
7. Nakamura H., Yuasa I., Umetsu K., Nakagawa M., Nanba E., Kimura K., Biochem. Biophys. Res. Commun., 276, 779-784 (2000).
8. Yuasa I., Nakamura H., Henke L., Henke J., Nakagawa M., Irizawa Y., Umetsu K., J. Hum. Genet., 46, 572-578 (2001).
9. Eap C. B., Baumann P., Electrophoresis, 9, 650-654 (1988).
10. Hervé F., Duché J. C., Barré J., Millot M. C., Tillement J. P., J. Chromatogr., 577, 43-59 (1992).
11. Hervé F., Millot M. C., Eap C. B., Duché J. C., Tillement J. P., J. Chromatogr. B, Biomed. Appl., 678, 1-14 (1996).
12. Fitos I., Visy J., Zsila F., Bikádi Z., Mády G., Simonyi M., Biochem. Pharmacol., 67, 679-688 (2004).
13. Eap C. B., Cuendet C., Baumann P., Clin. Pharmacol. Ther., 47, 338-346 (1990).
14. Hervé F., Duché J. C., d'Athis P., Marché C., Barré J., Tillement J. P., Pharmacogenetics, 6, 403-415 (1996).
15. Hervé F., Caron G., Duché J. C., Gaillard P., Abd. Rahman N., Tsantili-Kakoulidou A., Carrupt P. A., D'Athis P., Tillement J. P., Testa B., Mol. Pharmacol., 54, 129-138 (1998).
16. Taheri S., Cogswell L. P. 3rd, Gent A., Strichartz G. R., J. Pharmacol. Exp. Ther., 304, 71-80 (2003).
17. Zarghi A., Foroutan S. M., Shafaati A., Khoddam A., Farmaco, 60, 789-792 (2005).
18. Abou-Auda H. S., Najjar T. A., Al-Khamis K. I., Al-Hadiya B. M., Ghilzai N. M., Al-Fawzan N. F., J. Pharm. Biomed. Anal., 22, 241-249 (2000).